Spruce Biosciences Inc

General ticker "SPRB" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $19.5M

Spruce Biosciences Inc does not follow the US Stock Market performance with the rate: -27.1%.

Estimated limits based on current volatility of 2.8%: low 0.37$, high 0.40$

Factors to consider:

  • Current price 70.2% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.27$, 3.55$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.24$, 3.46$]

Financial Metrics affecting the SPRB estimates:

  • Negative: Non-GAAP EPS, $ of -1.25 <= 0.10
  • Negative: Operating profit margin, % of -83.75 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -34.41 <= 2.35
  • Positive: Interest expense per share, $ of 0.01 <= 0.14

Similar symbols

Short-term SPRB quotes

Long-term SPRB plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $10.09MM
Operating Expenses $42.07MM $47.28MM $62.08MM
Operating Income $-42.07MM $-47.28MM $-51.99MM
Non-Operating Income $-0.23MM $1.10MM $4.07MM
Interest Expense $0.34MM $0.42MM $0.48MM
R&D Expense $30.70MM $35.20MM $49.43MM
Income(Loss) $-42.29MM $-46.18MM $-47.92MM
Profit(Loss) $-42.29MM $-46.18MM $-47.92MM
Stockholders Equity $111.37MM $68.49MM $76.51MM
Assets $126.49MM $85.65MM $103.95MM
Operating Cash Flow $-35.88MM $-41.68MM $-33.27MM
Capital expenditure $0.09MM $0.01MM $0.01MM
Investing Cash Flow $-79.17MM $23.69MM $55.78MM
Financing Cash Flow $0.64MM $-0.24MM $49.14MM
Earnings Per Share* $-1.83 $-1.92 $-1.24

* EPS are Split Adjusted, recent splits may be reflected with a delay.